Malignant Tumor

Oncology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alpha Tau Medical
Alpha Tau MedicalJERUSALEM, Israel
1 program
Experimental: DaRT seedsN/A1 trial
Active Trials
NCT05781555Recruiting100Est. Apr 2027
Novian Health
Novian HealthFrance - Evry
1 program
Novilase Interstitial Laser TherapyN/A1 trial
Active Trials
NCT01478438UnknownEst. Aug 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Alpha Tau MedicalExperimental: DaRT seeds
Novian HealthNovilase Interstitial Laser Therapy

Clinical Trials (2)

Total enrollment: 100 patients across 2 trials

NCT05781555Alpha Tau MedicalExperimental: DaRT seeds

A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors

Start: Mar 2023Est. completion: Apr 2027100 patients
N/ARecruiting
NCT01478438Novian HealthNovilase Interstitial Laser Therapy

A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers

Start: Apr 2012Est. completion: Aug 2021
N/AUnknown

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 100 patients
2 companies competing in this space